Nathan X. Yu
- Co-authors
- Bennett MaThomayant PrueksaritanontDennis DeanConrad E. RaabGeorge R. LankasClay B. FrederickWilliam H. SchaeferLori Mixson
- Topics
- Pharmacogenetics and Drug Metabolism (4 papers)Drug Transport and Resistance Mechanisms (2 papers)Eicosanoids and Hypertension Pharmacology (2 papers)
- Cited by
- PharmacologyOncologyBiochemistry
- Journals
- Journal of the American Chemical SocietyJournal of Pharmacology and Experimental TherapeuticsTetrahedron Letters
- Partner nations
- United StatesJapan
In The Last Decade
Nathan X. Yu
13 papers receiving 367 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 140
- Pharmacology 138
- Surgery 104
- Oncology 98
- Pharmacology 44
Countries citing papers authored by Nathan X. Yu
This map shows the geographic impact of Nathan X. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan X. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan X. Yu more than expected).
Fields of papers citing papers by Nathan X. Yu
This network shows the impact of papers produced by Nathan X. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan X. Yu. The network helps show where Nathan X. Yu may publish in the future.
Co-authorship network of co-authors of Nathan X. Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan X. Yu. A scholar is included among the top collaborators of Nathan X. Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan X. Yu. Nathan X. Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 6 | |
| 4 | 9 | |
| 5 | 5 | |
| 6 | 13 | |
| 7 | 3 | |
| 8 | 145 | |
| 9 | 105 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | 19 | |
| 13 | 61 |
About Nathan X. Yu
Nathan X. Yu is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 13 papers that have together received 381 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Pharmacology (138 citations), Oncology (98 citations) and Biochemistry (19 citations). Nathan X. Yu has collaborated with scholars based in United States and Japan. Frequent co-authors include Bennett Ma, Thomayant Prueksaritanont, Dennis Dean, Conrad E. Raab, George R. Lankas, Clay B. Frederick, William H. Schaefer, Lori Mixson, Mark D. Distefano and Gloria Y. Kwei. Their work appears in journals such as Journal of the American Chemical Society, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.